Is Prehospital Treatment of Acute Stroke too Expensive? An Economic Evaluation Based on the First Trial

被引:78
作者
Dietrich, Martin [1 ]
Walter, Silke [2 ]
Ragoschke-Schumm, Andreas [1 ]
Helwig, Stefan [2 ]
Levine, Steven [3 ,4 ,5 ]
Balucani, Clotilde [3 ,4 ,5 ]
Lesmeister, Martin [2 ]
Haass, Anton [2 ]
Liu, Yang [2 ]
Lossius, Hans-Morten [6 ]
Fassbender, Klaus [2 ]
机构
[1] Univ Saarland, Chair Business Adm & Hlth Serv Management Res, DE-66421 Homburg, Germany
[2] Univ Saarland, Dept Neurol, DE-66421 Homburg, Germany
[3] SUNY Coll Med & Downstate Med Ctr, Dept Neurol, Brooklyn, NY USA
[4] SUNY Coll Med & Downstate Med Ctr, Stroke Ctr, Brooklyn, NY USA
[5] Kings Cty Hosp Ctr, Brooklyn, NY USA
[6] Norwegian Air Ambulance Fdn, Res & Dev, Oslo, Norway
关键词
Acute stroke; Prehospital stroke treatment; Benefit-cost ratio; Cost effectiveness; Mobile stroke unit; TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; COST-EFFECTIVENESS; MOBILE STROKE; INTRAVENOUS THROMBOLYSIS; ALTEPLASE; TIME; UNIT; IMPLEMENTATION; GUIDELINES;
D O I
10.1159/000371427
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Recently, a strategy for treating stroke directly at the emergency site was developed. It was based on the use of an ambulance equipped with a scanner, a point-ofcare laboratory, and telemedicine capabilities (Mobile Stroke Unit). Despite demonstrating a marked reduction in the delay to thrombolysis, this strategy is criticized because of potentially unacceptable costs. Methods: We related the incremental direct costs of prehospital stroke treatment based on data of the first trial on this concept to one year direct cost savings taken from published research results. Key parameters were configuration of emergency medical service personnel, operating distance, and population density. Model parameters were varied to cover 5 different relevant emergency medical service scenarios. Additionally, the effects of operating distance and population density on benefit-cost ratios were analyzed. Results: Benefits of the concept of pre-hospital stroke treatment outweighed its costs with a benefit- cost ratio of 1.96 in the baseline experimental setting. The benefit-cost ratio markedly increased with the reduction of the staff and with higher population density. Maximum benefit- cost ratios between 2.16 and 6.85 were identified at optimum operating distances in a range between 43.01 and 64.88 km (26.88 and 40.55 miles). Our model implies that in different scenarios the Mobile Stroke Unit strategy is costefficient starting from an operating distance of 15.98 km (9.99 miles) or from a population density of 79 inhabitants per km(2) (202 inhabitants per square mile). Conclusion: This study indicates that based on a one-year benefit-cost analysis that prehospital treatment of acute stroke is highly costeffective across a wide range of possible scenarios. It is the highest when the staff size of the Mobile Stroke Unit can be reduced, for example, by the use of telemedical support from hospital experts. Although efficiency is positively related to population density, benefit-cost ratios can be greater than 1 even in rural settings. (C) 2014 S. Karger AG, Basel
引用
收藏
页码:457 / 463
页数:7
相关论文
共 32 条
[1]   Guidelines for the early management of adults with ischemic stroke -: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups (Reprinted from Stroke, vol 38, pg 1655-1711, 2007) [J].
Adams, Harold P., Jr. ;
del Zoppo, Gregory ;
Alberts, Mark J. ;
Bhatt, Deepak L. ;
Brass, Lawrence ;
Furlan, Anthony ;
Grubb, Robert L. ;
Higashida, Randall T. ;
Jauch, Edward C. ;
Kidwell, Chelsea ;
Lyden, Patrick D. ;
Morgenstern, Lewis B. ;
Qureshi, Adnan I. ;
Rosenwasser, Robert H. ;
Scott, Phillip A. ;
Wijdicks, Eelco F. M. .
CIRCULATION, 2007, 115 (20) :E478-E534
[2]   Acute stroke care in the US - Results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry [J].
Arora, S ;
Broderick, JP ;
Frankel, M ;
Heinrich, JP ;
Hickenbottom, S ;
Karp, H ;
LaBresh, KA ;
Malarcher, A ;
Mensah, G ;
Moomaw, CJ ;
Reeves, MJ ;
Schwamm, L ;
Weiss, P .
STROKE, 2005, 36 (06) :1232-1240
[3]   Is it beneficial to increase the provision of thrombolysis?- a discrete-event simulation model [J].
Barton, M. ;
McClean, S. ;
Gillespie, J. ;
Garg, L. ;
Wilson, D. ;
Fullerton, K. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2012, 105 (07) :665-673
[4]   Real-life costs and effects of an implementation program to increase thrombolysis in stroke [J].
Dirks, Maaike ;
Baeten, Stefan A. ;
Dippel, Diederik W. J. ;
van Exel, N. Job A. ;
van Wijngaarden, Jeroen D. H. ;
Huijsman, Robbert ;
Koudstaal, Peter J. ;
Niessen, Louis W. .
NEUROLOGY, 2012, 79 (06) :508-514
[5]   Economic Impact of Using Additional Diagnostic Tests to Better Select Patients With Stroke for Intravenous Thrombolysis in the United Kingdom [J].
Earnshaw, Stephanie R. ;
McDade, Cheryl ;
Chapman, Ann-Marie ;
Jackson, Daniel ;
Schwamm, Lee .
CLINICAL THERAPEUTICS, 2012, 34 (07) :1544-1558
[6]   Effect of the Use of Ambulance-Based Thrombolysis on Time to Thrombolysis in Acute Ischemic Stroke A Randomized Clinical Trial [J].
Ebinger, Martin ;
Winter, Benjamin ;
Wendt, Matthias ;
Weber, Joachim E. ;
Waldschmidt, Carolin ;
Rozanski, Michal ;
Kunz, Alexander ;
Koch, Peter ;
Kellner, Philipp A. ;
Gierhake, Daniel ;
Villringer, Kersten ;
Fiebach, Jochen B. ;
Grittner, Ulrike ;
Hartmann, Andreas ;
Mackert, Bruno-Marcel ;
Endres, Matthias ;
Audebert, Heinrich J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (16) :1622-1631
[7]   Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke [J].
Ehlers, Lars ;
Andersen, Grethe ;
Clausen, Lone Beltoft ;
Bech, Merete ;
Kjolby, Mette .
STROKE, 2007, 38 (01) :85-89
[8]   Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials [J].
Emberson, Jonathan ;
Lees, Kennedy R. ;
Lyden, Patrick ;
Blackwell, Lisa ;
Albers, Gregory ;
Bluhmki, Erich ;
Brott, Thomas ;
Cohen, Geoff ;
Davis, Stephen ;
Donnan, Geoffrey ;
Grotta, James ;
Howard, George ;
Kaste, Markku ;
Koga, Masatoshi ;
von Kummer, Ruediger ;
Lansberg, Maarten ;
Lindley, Richard I. ;
Murray, Gordon ;
Olivot, Jean Marc ;
Parsons, Mark ;
Tilley, Barbara ;
Toni, Danilo ;
Toyoda, Kazunori ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Whiteley, William ;
del Zoppo, Gregory J. ;
Baigent, Colin ;
Sandercock, Peter ;
Hacke, Werner .
LANCET, 2014, 384 (9958) :1929-1935
[9]   Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke [J].
Fagan, SC ;
Morgenstern, LB ;
Petitta, A ;
Ward, RE ;
Tilley, BC ;
Marler, JR ;
Levine, SR ;
Broderick, JP ;
Kwiatkowski, TG ;
Frankel, M ;
Brott, TG ;
Walker, MD .
NEUROLOGY, 1998, 50 (04) :883-890
[10]   Mobile stroke unit for hyperacute stroke treatment [J].
Fassbender, K ;
Walter, S ;
Liu, Y ;
Muehlhauser, F ;
Ragoschke, A ;
Kuehl, S ;
Mielke, O .
STROKE, 2003, 34 (06) :E44-E44